OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

2,678 JAZZ shares were withheld to cover taxes or exercise cost (Officer) | OQRO

Home
Insider trades
Jazz Pharmaceuticals
2,678 JAZZ shares were withheld to cover taxes or exercise cost (Offic

Insider trades

Insider trade

2,678 JAZZ shares were withheld to cover taxes or exercise cost (Officer)

Traded Jun 30, 2026 · Filed Jul 3, 2026

JAZJazz PharmaceuticalsJAZZ

2,678
Shares · @ $237.72

Why it stands out

Routine share withholding; mechanical by default.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 30, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 3, 2026

OfficerTax withholding

Context

Classification

tax withholding

Code F — shares delivered to pay exercise price or tax liability

Planned / mechanical clue

Tax mechanics (code F)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001783908-26-000019

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Jul 3, 2026, 2:09 AM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Jazz Pharmaceuticals plc

Issuer CIK

1232524

Ticker

JAZZ

Reporting person

Neena M Patil

Relationship

Officer

Officer title

EVP & Chief Legal Officer

Security

Ordinary Shares

Table

Non-derivative (Table I)

Transaction date

Jun 30, 2026

Transaction code

Shares / units

2,678

Price per share

$237.72

Acquired / disposed

Disposed (D)

Shares owned after

48,871

Ownership form

Direct

Amendment

Footnotes from the filing

Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Around the same time

Bruce C Cozadd (Director) sold ~$1.44M of Jazz Pharmaceuticals

Planned saleFiled 3mo ago

Samantha PearceEVP, Chief Commercial Officer

Filed 3mo ago

2,527Shares · @ $237.72

Traded Jun 30 · filed 3 days later

Routine share withholding; mechanical by default.

More Official record

Renee D GalaPresident & CEO

Filed 3mo ago

4,835Shares · @ $237.72

Traded Jun 30 · filed 3 days later

Routine share withholding; mechanical by default.

More Official record